BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sherbuk JE, McManus KA, Rogawski McQuade ET, Knick T, Henry Z, Dillingham R. Hepatitis C Within a Single Health System: Progression Along the Cascade to Cure Is Higher for Those With Substance Misuse When Linked to a Clinic With Embedded Support Services. Open Forum Infect Dis 2018;5:ofy202. [PMID: 30255113 DOI: 10.1093/ofid/ofy202] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Nakayama JY, Ho J, Cartwright E, Simpson R, Hertzberg VS. Predictors of progression through the cascade of care to a cure for hepatitis C patients using decision trees and random forests. Comput Biol Med 2021;134:104461. [PMID: 33975209 DOI: 10.1016/j.compbiomed.2021.104461] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Sherbuk JE, Knick TK, Canan C, Ross P, Helbert B, Cantrell ES, Cantrell CJ, Stallings R, Barron N, Jordan D, McManus KA, Dillingham R. Development of an Interdisciplinary Telehealth Model of Provider Training and Comprehensive Care for Hepatitis C and Opioid Use Disorder in a High-Burden Region. J Infect Dis 2020;222:S354-64. [PMID: 32877562 DOI: 10.1093/infdis/jiaa141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Winetsky D, Burack D, Antoniou P, Garcia B, Gordon P, Scherer M. Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program. J Infect Dis 2020;222:S392-400. [PMID: 32877544 DOI: 10.1093/infdis/jiaa142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sherbuk JE, Tabackman A, McManus KA, Kemp Knick T, Schexnayder J, Flickinger TE, Dillingham R. A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South. Harm Reduct J 2020;17:64. [PMID: 32948189 DOI: 10.1186/s12954-020-00409-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
5 Barbosa C, Fraser H, Hoerger TJ, Leib A, Havens JR, Young A, Kral A, Page K, Evans J, Zibbell J, Hariri S, Vellozzi C, Nerlander L, Ward JW, Vickerman P. Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs. Addiction 2019;114:2267-78. [PMID: 31307116 DOI: 10.1111/add.14731] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
6 Sherbuk JE, McManus KA, Kemp Knick T, Canan CE, Flickinger T, Dillingham R. Disparities in Hepatitis C Linkage to Care in the Direct Acting Antiviral Era: Findings From a Referral Clinic With an Embedded Nurse Navigator Model. Front Public Health 2019;7:362. [PMID: 31828056 DOI: 10.3389/fpubh.2019.00362] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]